Chapter 36 Flashcards
Alterations of Pulmonary Function
signs and symptoms of pulmonary disease
- _____ and _____
- pulmonary disease is associated with many sings and symptoms, and their specific characteristics often help in identifying the underlying disorder. the most common characteristics are _____ and _____
hemoptysis abnormal sputum cyanosis chest pain clubbing altered breathing patterns hyperventilation hypoventilation
dyspnea
cough
dyspnea
cough
sings and symptoms of pulmonary disease dyspnea -subjective sensation of \_\_\_\_\_ -severe dyspnea --\_\_\_\_\_ of the nostrils --use of \_\_\_\_\_ of respiration --retraction of the \_\_\_\_\_
- dyspnea on exertion
- -_____ with activity
- _____: sitting up in a forward leaning position generally relieves which breathing
- -orthopnea is generally relieved by _____ in a _____ or supporting the upper body on _____
uncomfortable breathing flaring accessory muscles intercostal spaces SOB orthopnea sitting up forward leaning posture several pillows
signs and symptoms of pulmonary disease
hypoventilation
-_____ is inadequate in relationship to the _____
-leads to _____ from _____
-is caused by _____, _____, or altered neurologic control of _____
alveolar ventilation metabolic demands respiratory acidosis hypercapnia/high CO2 levels airway obstruction chest wall restriction breathing
signs and symptoms of pulmonary diseases hyperventilation -\_\_\_\_\_ exceeds the \_\_\_\_\_ -leads to \_\_\_\_\_ from \_\_\_\_\_ -is caused by \_\_\_\_\_, \_\_\_\_\_, or severe \_\_\_\_\_
alveolar ventilation metabolic demands respiratory alkalosis hypocapnia/low CO2 levels anxiety head injury hypoxemia
clubbing
- clubbing is the selective _____ of the end (_____) of a _____ and is commonly associated with diseases that interfere with _____ such as:
- -_____, _____, _____, _____, and _____
bulbous enlargement distal segment digit oxygenation bronchiectasis cystic fibrosis pulmonary fibrosis lung abscess congenital heart disease
conditions caused by pulmonary disease or injury
hypoxemia vs hypoxia
-PaO2: oxygenation of _____
-PAO2: the amount of oxygen in the _____
- the _____ is a measure of the difference between the alveolar concentration of oxygen and the arterial concentration of oxygen. it is used in diagnosing the source of _____
- measurement helps isolate the location of the problem as either _____ (within the lungs) or _____ (somewhere else in the body)
arterial blood alveoli alveolar-arterial gradient hypoxemia intrapulmonary extrapulmonary
reduced oxygenation of cells in tissues
hypoxia
reduced oxygenation of arterial blood (reduced _____), is caused by respiratory alternation
hypoxemia
PaO2
conditions caused by pulmonary disease or injury hypoxemia vs hypoxia
- _____: or reduced oxygenation of arterial blood (reduced PaO2) is caused by _____
- _____ of _____ through the _____ is impaired if the alveolocapillary membrane is _____ or if the surface area available for _____ is _____
- _____ and _____ cause hypoxemia by the mechanism of abnormal _____, as occurs with _____ (tissue swelling) and _____ (formation of fibrous lesions), _____ the time required for _____ across the _____ membrane so bottom line point this causes of impairing _____
hypoxemia respiratory alternation diffusion oxygen alveolocapillary membrane thickened diffusion decreased pulmonary edema pulmonary fibrosis thickness pulmonary edema pulmonary fibrosis increases diffusion alveolocapillary alveolocapillary membrane diffusion
pleural abnormalities pleural effusion -presence of \_\_\_\_\_ in the \_\_\_\_\_ -\_\_\_\_\_ effusion --is \_\_\_\_\_ and diffuses out of the \_\_\_\_\_
- _____ effusion
- -is less _____ and contains high concentrations of _____ and _____
fluid pleural space transudative watery capillaries exudate watery white blood cells plasma proteins
exudative effusion
- exudative effusion contains high concentrations of _____
- exudative effusion may occur in response to an _____
- the presence of a _____ can trigger exudative effusion
- exudative effusion is a result of _____
white blood cells
inflammatory process
malignant cancer
increased capillary permeability
pleural abnormalities
empyema
-infected _____
-_____ in the _____: causes pulmonary infections (_____, _____), infected _____
clinical manifestations
-_____, _____, _____ (rapid heart rate), _____, and _____
treatment
- administration of _____
- drainage of the _____ with a _____
- severe cases: _____, instillation of _____, or _____ (_____) injected into the _____
pus pleural space pneumonia abcesses wounds cyanosis fever tachycardia cough pleural pain antimicrobial medications pleural space chest tube ultrasound-guided pleural drainage fibrinolytic agents deoxyribonuclease DNase pleural space
restrictive lung diseases
- restrict the _____
- the lungs are unable to _____ normally, diminishing the amount of _____ that can be _____
obstructive lung diseases
- affect _____
- _____ into and out of the lung is _____. increased resistance to air flow caused by _____
lung volume expand gas inspired gas flow airflow obstructed narrowing of airways
CXR abnormalities terms
- _____ and _____: air trapping in the _____ and _____
- _____ or _____: _____ of lung tissue
- _____ or _____: cavities
- _____: nodules
asthma and emphysema alveoli airways pneumonia pulmonary edema consolidation accesses or tuberculosis lung cancer
restrictive lung disorders
- aspiration
- _____
- bronchiectasis, bronchitis
- _____
- inhalational disorders
- pneumoconiosis
- allergic alveolitis
- _____
- _____
atelectasis
pulmonary fibrosis
pulmonary edema
acute respiratory distress syndrome
atelectasis
-a loss of _____ caused by _____ of _____ and subsequent collapse of part of the _____
etiology:
- obstructive (e.g. _____)
- non obstructive- _____
- pneumothorax
- surfactant deficiency
- _____ (_____)
- asbestosis
lung volume deflation alveoli lung tumor pleural effusion postoperative within 72 hours of surgery
atelectasis
- _____ of _____
- compression atelectasis
- -_____ on the _____
- absorption atelectasis
- -gradual absorption of _____ from _____ or _____
- surfactant impairment
- -_____ production or inactivation of _____
clinical manifestations
-_____, _____, _____, and _____
- treatment: _____
- -_____
collapse lung tissue external compression lung air obstructed hypoventilated alveoli decreased surfactant dyspnea cough fever leukocytosis prevention deep breathing
_____ supine left lung _____ in _____
atelectasis
reduced
volume
restrictive lung disorders
pulmonary fibrosis
-excessive amount of _____ or _____ in the _____
-_____: no specific cause
–clinical manifestations: increasing _____ on _____
- treatment
- -_____; combined treatment with _____ drugs; _____ drugs such as (_____ and _____), interferon, and _____ agents; _____
fibrous connective lung idiopathic dyspnea exertion corticosteroids cytotoxic antifibrotic N acetylcysteine pirfenidone anticoagulant lung transplantation
restrictive lung disorders
pulmonary edema
-excess _____ in the lung from disturbances of _____, _____, or _____
-most common cause of pulmonary edema: _____
-clinical manifestations: _____, _____, _____, and increased work of _____
water capillary hydrostatic pressure capillary oncotic pressure capillary permeability left-sided heart disease dyspnea orthopnea hypoxemia breathing
pulmonary edema
-perihilar, _____ shadow of _____ or _____ appearance. the hatched lines are the _____ (_____ which represent prominent _____ vessels)
interstitial opacities butterfly bat wings septal lines kerley lines interlobular lymphatic
kerley b lines
- these are _____ lines at the lung _____. these lines represent _____ which are usually less than 1 cm in length and parallel to one another at _____ to the _____
- they are located peripherally in contact with the _____, but are generally absent along _____
- they may be seen in any zone but are most frequently observed at the _____ at the _____ on the PA radiograph
short parallel periphery interlobular septa right angles pleura pleura fissural surfaces lung bases costophrenic angles
restrictive lung disorders ARDS -\_\_\_\_\_ (ALI) or \_\_\_\_\_ (ARDS) --is a \_\_\_\_\_ form of \_\_\_\_\_ characterized by \_\_\_\_\_ and \_\_\_\_\_ --injury to the \_\_\_\_\_ --increased \_\_\_\_\_ --inflammation --\_\_\_\_\_ --edema and atelectasis
acute lung injury acute respiratory distress syndrome fulminant respiratory failure acute lung inflammation diffuse alveolocapillary injury pulmonary capillary endothelium capillary permeability surfactant inactivation
ARDS pathophysiology
- in acute respiratory distress syndrome (ARDS), _____ and _____ fill with _____ as a result of inactivation of _____ and the impairment of _____
- _____ release inflammatory mediators such as _____, _____, _____, and _____
alveoli respiratory bronchioles fluid surfactant type II alveolar cells neutrophils proteolytic enzymes oxygen-free radicals prostaglandins leukotrienes platelet activating factor